222 related articles for article (PubMed ID: 23548800)
1. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
3. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
[TBL] [Abstract][Full Text] [Related]
4. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway.
Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z
Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).
Tsotakos NE; Sagnou M; Kotsopoulou ES; Tsilibary EC; Drossopoulou GI
BMC Cell Biol; 2013 Jun; 14():28. PubMed ID: 23768159
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression.
Deb DK; Wang Y; Zhang Z; Nie H; Huang X; Yuan Z; Chen Y; Zhao Q; Li YC
J Biol Chem; 2011 Sep; 286(37):32011-7. PubMed ID: 21803771
[TBL] [Abstract][Full Text] [Related]
7. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.
Okamura M; Takano Y; Saito Y; Yao J; Kitamura M
Nephrol Dial Transplant; 2009 Oct; 24(10):3006-12. PubMed ID: 19474283
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
9. Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes.
Drossopoulou GI; Tsotakos NE; Tsilibary EC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F594-603. PubMed ID: 19605546
[TBL] [Abstract][Full Text] [Related]
10. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell.
Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H
Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769
[TBL] [Abstract][Full Text] [Related]
11. Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway.
Saito Y; Okamura M; Nakajima S; Hayakawa K; Huang T; Yao J; Kitamura M
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1436-44. PubMed ID: 20237236
[TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model.
Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F
J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β and vitamin D receptor are involved in β-catenin and snail signaling in high glucose-induced epithelial-mesenchymal transition of mouse podocytes.
Guo J; Xia N; Yang L; Zhou S; Zhang Q; Qiao Y; Liu Z
Cell Physiol Biochem; 2014; 33(4):1087-96. PubMed ID: 24732862
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and proteinuria: a critical review of molecular bases and clinical experience.
Pérez-Gómez MV; Ortiz-Arduán A; Lorenzo-Sellares V
Nefrologia; 2013; 33(5):716-26. PubMed ID: 24089164
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Receptor/Vitamin D Response Element Directly Modulate Nestin Transcription to Ameliorate PAN-Induced Podocyte Morphological Changes.
Zhang Q; Jiang X; Wen D; Zhang Y; Mao J; Ni L; Chen J
Nephron; 2022; 146(6):624-636. PubMed ID: 35526529
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
18. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways.
Zitman-Gal T; Golan E; Green J; Bernheim J; Benchetrit S
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):1-7. PubMed ID: 22531461
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
